Skip to content

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp

Segments

By geography

See full
Net sales attributed to all foreign countries10%0.0%

Other financials

Income statement

See full
Revenue$2.7B-3.6%
Gross profit$1.0B-1.6%
Operating income$273.0M+130%
Net income$169.0M+117%
EPS (diluted)$0.66+117%

Balance sheet

See full
Cash & equivalents$562.0M-13.5%
Total debt$6.3B-35.5%
Total equity$14.1B+7.2%
Total assets$25.1B-11.0%

Cash flow

See full
Operating cash flow$257.0M+102%
CapEx$165.0M-7.8%
Free cash flow$92.0M+277%

Valuation

See full
Market cap$20.23B+10.7%
Enterprise value$26.01B+7.5%
P/E24.6×
P/S1.9×+0.3×

Profitability

See full
Gross margin36.3%+0.2pp
Operating margin-3.2%-1.4pp
Net margin7.6%+5.2pp
FCF margin3.7%-1.3pp

Returns & leverage

See full
Return on equity6%+4.0pp
Debt / equity0.4×-0.3×
Current ratio1.5×-0.4×